CXCL12 has downstream effects on cancer cell proliferation, as well as myeloid cell and T‐cell recruitment and targeting CXCL12 synergises with checkpoint blockade in pancreatic cancer [17]. This evidence concerns the gene CXCL12 and familial pancreatic carcinoma.